Overview

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to: Improve the effectiveness of vaccinations by identifying the effect of cholesterol medication, statins, on immune responses.
Phase:
Phase 1
Details
Lead Sponsor:
University of Florida
Treatments:
Atorvastatin
Atorvastatin Calcium
Heptavalent Pneumococcal Conjugate Vaccine